Voyager Therapeutics
VYGR
VYGR
58 hedge funds and large institutions have $51.2M invested in Voyager Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
16% less funds holding
Funds holding: 69 → 58 (-11)
45% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 22
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
58
Holding in Top 10
1
Calls
$899K
Puts
$369K
Top Buyers
| 1 | +$8.43M | |
| 2 | +$1.2M | |
| 3 | +$853K | |
| 4 |
D.E. Shaw & Co
New York
|
+$797K |
| 5 |
Millennium Management
New York
|
+$406K |
Top Sellers
| 1 | -$9.77M | |
| 2 | -$2.48M | |
| 3 | -$1.26M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.15M |
| 5 |
JPMorgan Chase & Co
New York
|
-$730K |